News

California’s Board of Pharmacy (BOP) has been mulling a proposal to restrict access to what are called “category one sterile compounds.” Targeted elements include glutathione, vitamin B12, and other substances often relied on by Lyme patients and others who are... Read More »

by Bonnie Crater, Center for Lyme Action As you can see from the table below, Congress has started working on Fiscal Year 2025 appropriations. And as we reported in July and then August, we continue to make progress in the House and Senate on increases for Lyme and tick-borne... Read More »

“My family knows that after I die, my tissues will be donated to Lyme Disease Biobank to provide researchers with the vital material they need to solve this horrible disease. I urge anyone with chronic/persistent Lyme to register with NDRI today. Let’s end this suffering... Read More »

The Lyme ImmunoBlot test first introduced by IGeneX in 2017 has been augmented. Now converted to a test kit, it has received FDA clearance. The name of the test is iDart™ Lyme IgG ImmunoBlot Kit. It’s a stand-alone test for the detection of IgG antibodies against... Read More »

By Wayne Lewis, UCLA For some unlucky people, time in the great outdoors leads to Lyme disease, an illness causing head, joint and muscle pain, flu-like symptoms, fatigue, and sometimes a rash. Left untreated, those effects can turn debilitating and expand to include paralysis,... Read More »

While Lyme disease is the most recognized and prevalent tick-borne disease in the United States, other infections transmitted through tick bites can be equally or even more dangerous. One of these is the Powassan virus (POWV). Erich Mackow, PhD, an internationally recognized... Read More »

A Celebration of Life for Pat Smith will be held September 7 in Neptune, New Jersey. It will also be livestreamed. Click here for details. From the Lyme Disease Association website: It is with deep sadness and a profound sense of loss that we share the news of the passing of our... Read More »

The California State Board of Pharmacy (BOP) is expected to block access to an entire class of alternative treatments including IV glutathione and methylcobalamin (a form of vitamin B12). These are relied on by many people with persistent Lyme disease and other chronic illnesses,... Read More »

On September 12, the California State Board of Pharmacy is expected to vote to eliminate access to safe and critical Category 1 substances like methylcobalamin (a form of vitamin B12) and glutathione infusions. These are relied upon by some of California’s most vulnerable... Read More »